Skip to content

HBOT Effect on Chronic Pain Syndrome With a History of Psychological Trauma

The Effect of Hyperbaric Oxygen on Patients Suffering From Chronic Pain Syndrome (Fibromyalgia) With a History of Psychological Trauma

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03376269
Acronym
HBOTCSA
Enrollment
30
Registered
2017-12-18
Start date
2014-12-31
Completion date
2017-11-30
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia, Chronic Pain Syndrome

Keywords

more than 1 year

Brief summary

The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) on 2 types of patients' population suffering from chronic pain syndrome (Fibromyalgia): patients with history of psychological trauma and patients with history of traumatic brain injury.

Detailed description

This study is a prospective clinical trial. After signing a written informed consent, all patients will be invited to medical evaluation including pain sensitivity examination and a series of questionnaires. In addition, all patients will have chest X-ray, cognitive evaluation, brain MRI and brain Single-photon emission computed tomography (SPECT) . A second brain MRI, brain SPECT, pain sensitivity evaluation and questionnaires will be done after 3 months of treatment (60 sessions of HBOT). The HBOT procedure will be performed at the Sagol center for hyperbaric medicine and research of Assaf Harofeh Medical Center, Israel. The following HBOT protocol will be applied for all patients: 12 weeks, 5 times per week, daily administration of 100% O2 for 90 minutes at a pressure of 2 absolute atmospheres (ATA) including 5 minutes air breaks every 30 minutes. Patients with history of psychological trauma are also being treated with creative art psychotherapy. These patients will be randomly assigned to one of the two groups: (1) single intervention with creative art psychotherapy (psychotherapy group); (2) combined concurrent intervention of HBOT and creative art psychotherapy. Groups 1 will serve as controls during the first 3 months and then will be crossed to get HBOT. Before the cross to the HBOT they will have 2nd full evaluation (questioners and brain imaging).

Interventions

BIOLOGICALHBOT

•HBOT of 2 ATA for 90 minutes O2 100%, for 60 treatments

BEHAVIORALPsychotherapy

creative art psychotherapy which includes self drawing and daily diary alongside professional psychotherapy sessions

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Females * Age over 18 * Known fibromyalgia (chronic pain syndrome) for more than 1 year

Exclusion criteria

* Any past hyperbaric treatment prior to inclusion * Patients with chest x-ray pathology incompatible with hyperbaric environment * Patients with middle ear problems * Patients, who cannot pump, equals middle ear pressure, effectively * Patients who suffer from claustrophobia * Inability or Refusing to sign the Informed Consent Form

Design outcomes

Primary

MeasureTime frameDescription
Pain sensitivityChange After 3 monthsUsing (AlogMed) dolorimeter, pain sensitivity will be examined in 18 trigger points (scale0-18)
Brain microstructureChange after 3 monthsMRI dynamic tensor imaging sequence will be performed (DTI). Fractional anisotropy (FA) values will be assessed at base line and at 3 months. The changes at 3 months from baseline will be compared
Brain MetabolismChange after 3 monthsBrain metabolism will be assessed using SPECT at baseline, 3 monthsThe counts for each different Broadmann area values will be calculated. The changes at 3 months from baseline will be compared.

Secondary

MeasureTime frameDescription
Psychological symptomsChange after 3 monthsPsychological symptoms will be evaluated using Brief Symptom Inventory(BSI) questionnaire.(scale 0-20)
Sensory symptomsChange after 3 monthsSensory symptoms will be evaluated using the Sensory Profile questionnaires .
Fibromyalgia Impact on quality of lifeChange after 3 monthsEvaluated by Fibromyalgia Impact Questionnaire (FIQ).(scale 0-100)
Childhood trauma psychological effectsChange after 3 monthsChildhood trauma psychological effects will be evaluated using the Childhood Trauma Questionnaire (CTQ) questionnaires.(scale 0-125)
Somatoform Dissociation Questionnaire (SDQ-20)Change after 3 monthsDissociation symptoms will be evaluated using the Somatoform Dissociation Questionnaire (SDQ-20).
Short form health survey (sf-36)Change after 3 monthsQuality of live will be evaluated by Quality of Life RAND Short form 36 questionnaire (SF36).(scale 0-100) higher score means better outcome.
StressChange after 3 months tStress will be evaluated using the Perceived stress scale (PSS) questionnaire.(scale 0-51)

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026